Sermorelin
A growth hormone-releasing hormone analog studied for its role in stimulating endogenous GH release. Sermorelin is one of the longest-studied peptides in growth hormone signaling research.
The longest-studied GH signal.
Sermorelin is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH). It works upstream of growth hormone itself — signaling the pituitary gland to release GH through the body’s natural pulsatile rhythm rather than introducing exogenous hormone.
For women researchers exploring age-related GH decline, Sermorelin offers an unusually well-characterized tool. It has been studied since the 1980s, has been in clinical use longer than most peptides in this family, and has a longer published research base than nearly any GH-related compound.
Published research has documented Sermorelin’s role in stimulating endogenous GH release, supporting the metabolic and body composition effects associated with optimized growth hormone signaling, and contributing to recovery and sleep architecture research in aging populations.
Decades of GH research, condensed.
Pulsatile GH Release
Recovery & Sleep
Body Composition Research
Independently Tested. Verified by Batch.
Labeled amount per vial
Questions.
Research Use Only